Get the latest in ArisGlobal news and announcements
ArisGlobal to Co-Present “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology” at World Drug Safety Congress Americas
ArisGlobal is thrilled to announce their participation at the World Drug Safety Congress Americas, September 01 – 02, 2020. Along with a large drug manufacturer, they will be co-presenting a session titled “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology”.
ArisGlobal, is thrilled to be a Corporate Support Sponsor and to attend the SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando in Orlando, Florida from February 18 – 21, 2020, presented by the Cambridge Healthtech Institute.
ArisGlobal to Present “Automating Health Authority Correspondence and Commitments on a Unified Regulatory Platform” on Tuesday, February 11, 2020, at DIA Regulatory Submissions, Information and Document Management Forum (RSIDM).
Major Tobacco Manufacturer Selects LifeSphere® MultiVigilance to Automate All Global Internal Adverse Event Management Processes
A multinational tobacco products manufacturing company recently selected ArisGlobal’s LifeSphere® MultiVigilance 10, industry’s first and only automated adverse event platform for their global safety vigilance needs.
Linical a market-leading, midsized, global contract research organization (CRO) adopted ArisGlobal’s LifeSphere MultiVigilance as their primary global safety management system, industry’s first and only automated adverse event platform.
ArisGlobal announced it has made a number of new key leadership hires, with the express purpose of preparing for accelerated growth in North America, Europe, and Asia, and new product launches in 2020, according to President and CEO Sankesh Abbhi.
ArisGlobal and Soterius Extend Partnership with Global Delivery of LifeSphere® MultiVigilance and LifeSphere® Medical Information
ArisGlobal has expanded its partnership with Soterius, Inc., a global leader in providing drug safety and medical outsourcing services and solutions adding LifeSphere® MultiVigilance and LifeSphere® Medical Information to their service-oriented technology stack.
ArisGlobal’s LifeSphere MultiVigilance Goes Live with Top 5 Pharma, Delivering a Next-Generation Safety System to 2,300+ End Users
ArisGlobal successfully delivered the industry’s largest drug safety system implementation, going live on-time with its next-generation LifeSphere® MultiVigilance offering. LifeSphere MultiVigilance 10 is the industry’s only end-to-end safety system offering production-ready automation.
10 Life Sciences Companies Switch to ArisGlobal’s LifeSphere® MultiVigilance from Competing Safety Systems
ArisGlobal is proud to announce that ten life sciences companies have switched to its industry-leading LifeSphere® MultiVigilance drug safety system within the past 12 months. LifeSphere MultiVigilance is a next-generation, end-to-end safety system that has been developed in close partnership with industry leaders, including the FDA, Boehringer Ingelheim, Teva and AbbVie, among others.
ArisGlobal Releases Comprehensive Automated Literature Monitoring Solution for Improved Pharmacovigilance
ArisGlobal, the visionary technology provider of automated solutions for the life sciences industry, today announced the availability of LifeSphere® LitPro (LSLP), the life science industry’s first and only solution that effectively automates all steps in the medical literature monitoring (MLM) process required by most regulatory agencies.